Europe Daily News, 26 February 2024

Start
COMPETITION – Appeal brought on 4 January 2024 by Teva Pharmaceutical Industries Ltd and Cephalon Inc. against the judgment of the General Court of 18 October 2023 in Case T-74/21, Teva Pharmaceutical Industries and Cephalon Vs. Commission (Case C-2/24 P) Re: annulment of the decision of the European Commission in the case AT.39686-CEPHALON……
By: Mayer Brown
Previous Story

Understanding SEC’s Focus Amid Lack of Final AI Rules

Next Story

CFTC Seeks Comments on Use of AI in Derivatives Markets